LONGITUDINAL presents at BioSeed
LONGITUDINAL recently presented at BioSeed, introducing our approach to turning continuous wearable data into clinical trial decisions.
LONGITUDINAL advances development of its clinical trial decision intelligence platform
LONGITUDINAL continues to develop its approach for translating continuous wearable data into clearer clinical trial insight.
From wearable data to clinical trial decisions
Continuous data is becoming more common in clinical trials, but more data does not automatically create better decisions. Read how the real value comes from data capture moves to decision-ready insight.